Growth Characteristics in vitro of Myeloid Leukaemic Cells with t(6;9)

References

• Rowley J. D., Potter D. Chromosomal banding patterns in acute nonlymphocytic leukemia. Blood. 1976; 47: 705–721
   PubMed Web of Science ®Google Scholar
• Von Lindern M., Fornerod M., Soekarman N., Van Baal S., Jaegle M., Hagemeijer A., Bootsma D., Grosveld G. Translocation t(6;9) in acute nonlymphocytic leukaemia results in the formation of a DEK-CAN fusion gene. Baillieres Clin. Haematol. 1992; 5: 857–879
   PubMed Web of Science ®Google Scholar
• Von Lindern M., Poustka A., Lerach H., Grosveld G. The (6;9) chromosome translocation, associated with a specific subtype of acute nonlymphocytic leukemia, leads to aberrant transcription of a target gene on 9q34. Mol. Cell. Biol. 1990; 10: 4016–4026
   PubMed Web of Science ®Google Scholar
• Von Lindern M., Fornerod M., Van Baal S., Jaegle M., de Wit T., Buijs A., Grosveld G. The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can. and the expression of a chimeric leukemia-specificdek-can mRNA. Mol. Cell. Biol. 1992; 12: 1687–1697
   PubMed Web of Science ®Google Scholar
• Bernstein R., Cain M.-J., Cho J. Loss of the Y chromosome associated with translocation t(6;9)(p23;q34) in a patient with acute non-lymphocytic leukemia. Cancer Genet. Cvrogenet. 1989; 39: 81–87
   PubMed Web of Science ®Google Scholar
• Soekarman D., von Lindern M., Daenen S., de Jong B., Fonatsch C., Heinze B., Bartram C., Hagemeijer A., Grosveld G. The translocation (6;9)(p23;q34) shows consistent rearrangement of two genes and defines a myeloproliferative disorder with specific clinical features. Blood 1992; 79: 2990–2997
   PubMed Web of Science ®Google Scholar
• Pearson M. G., Vardiman J. W., Le Beau M. M., Rowley J. D., Schwartz S., Kerman S. L., Cohen M. M., Fleischman E. W., Prigogina E. L. Increased numbers of marrow basophils may be associated with a t(6;9) in ANLL. Am. J. Hematoi 1985; 18: 393–403
   PubMed Web of Science ®Google Scholar
• Bodger M. P., Morris C. M., Kennedy M. A., Bowen J. A., Hilton J. M., Fitzgerald P. H. Basophils (Bsp-1°) derive from the leukaemic clone in human myeloid leukemias involving the chromosome breakpoint 9q34. Blood 1989; 73: 777–781
   PubMed Web of Science ®Google Scholar
• Seabright M. A rapid banding technique for human chromosomes. Lancet 1971; II: 971–972
   Google Scholar
• Webber L. M., Garson O. M. Fluorodeoxyuridine synchronization of bone marrow culture. Cancer Genet. Cytogenet. 1983; 8: 123–132
   PubMed Web of Science ®Google Scholar
• Hollings P. E., Fitzgerald P. H. A characteristic CFU-GM growth pattern in acute promyelocytic leukemia. Leuk. Res. 1987; 11: 775–780
   PubMed Web of Science ®Google Scholar
• Hollings P. E., Rosman I., Beard M. E. J., Fitzgerald P. H. Abnormal chromosome 16 in clonogenic eosinophils from a case of acute myeloid leukemia (FAB, M2). Cancer Genet. Cytogenet. 1988; 31: 217–226
   PubMed Web of Science ®Google Scholar
• Burgess A. W., Wilson E. M. A., Metcalf D. Stimulation by human placental conditioned medium of haemopoietic colony formation by human marrow cells. Blood. 1977; 49: 573–583
   PubMed Web of Science ®Google Scholar
• Adriaansen H. J., van Dongen J. J. M., Hooijkass H., Hiihlen K., van't Veer M. B., Lowenberg B., Hagemeijer A. Translocation (6;9) may be associated with a specific TdT-positive immunological phenotype in ANLL. Leukemia 1988; 2: 136–140
   PubMed Web of Science ®Google Scholar
• Moore M. A. S., Williams N., Metcalf D. In vitro colony formation by normal and leukemic human hematopoietic cells: characterization of the colony forming cells. J. Natl. Cancer. Inst. 1973; 50: 603–623
   PubMed Web of Science ®Google Scholar
• Moore M. A. S., Spitzer G., Williams N., Metcalf D., Buckley J. Agar culture studies in 127 cases of untreated acute leukemia: the prognostic value of reclassification of leukemia according to in vitro growth characteristics. Blood 1974; 44: 1–18
   PubMed Web of Science ®Google Scholar
• Metcalf D. Detection and analysis of human granulocyte-monocyte precursors using semi-solid cultures. Clinics in Haematol 1979; 8: 263–285
   PubMedGoogle Scholar
• Horsman D. E., Kalousek D. K. Acute myelomonocytic leukemia (AML-M4) and translocation t(6;9)(p23;q34): Two additional patients with prominent myelodysplasia. Am. J. Hematol 1987; 26: 77–82
   PubMed Web of Science ®Google Scholar
• Keating M. J., Smith T. L., Kantarjian H., Cork A., Walters R., Trujillo J. M., McCredie K. B., Gehan E. A., Freireich E. J. Cytogenetic pattern in acute myelogenous leukemia. A major reproducible determinant of outcome. Leukemia 1988; 2: 403–412
   PubMed Web of Science ®Google Scholar
• Yunis J. J., Lobell M., Amesen M. A., Oken M. M., Mayer M. G., Rydell R. E., Brunning R. D. Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemia. Br. J. Haematol. 1988; 68: 189–194
   PubMed Web of Science ®Google Scholar
• Arthur D. C., Berger R., Golomb H. M., Swansbury G. J., Reeves B. R., Alimena G., Van Den Berghe H., Bloomfield C. D., de la Chapelle A., Dewald G. W., Garson O. M., Hagemeijer A., Kaneko Y., Mitelman F., Pierre R. V., Ruutu T., Sakurai M., Lawler S. D., Rowley J. D. The clinical significance of karyotype in acute myelogenous leukemia. Cancer Genet. Cytogenet. 1989; 40: 203–216
   PubMed Web of Science ®Google Scholar
• Fenaux P., Preudhomme C., Lai J. L., Morel P., Beuscart R., Bauters F. Cytogenetics and their prognostic value in de novo acute myeloid leukaemia; a report on 283 cases. Br. J. Haematol. 1989; 73: 61–67
   PubMed Web of Science ®Google Scholar
• Schiffer C. A., Lee E. J., Tomiyasu T., Wiernik P. H., Testa J. R. Prognostic impact of cytogenetic abnormalities in patients with de novo acute non-lymphocytic leukemia. Blood 1989; 73: 263–270
   PubMed Web of Science ®Google Scholar
• Spitzer G., Dicke K. A., Gehan E. A., Smith T., McCredie K. B., Barlogie B., Friereich E. J. A simplified in vitro classification for prognosis in adult acute leukemia: the application of in vitro results in remission predictive models. Blood 1976; 48: 795–806
   PubMed Web of Science ®Google Scholar
• Beran M., Reizenstein P., Udéaan A-M. Response to treatment in acute non-lymphocytic leukemia: prognostic value of colony forming and colony stimulating capacities of bone marrow and blood cells compared to other parameters. Br. J. Haematol. 1980; 44: 39–50
   PubMed Web of Science ®Google Scholar
• Mertelsmann R., Moore M. A. S., Broxmeyer H. E., Cirrincione C., Clarkson B. Diagnostic and prognostic significance of the CFU-c assay in acute nonlymphoblastic leukemia. Cancer Res. 1981; 41: 4844–4848
   PubMed Web of Science ®Google Scholar
• Griffin J. D., Löwenberg B. Clonogenic cells in acute myeloblasts leukemia. Blood 1986; 68: 1185–1195
   PubMed Web of Science ®Google Scholar
• Grignani F., Fagioli M., Alcalay M., Longo L., Pandolfi P. P., Donti E., Biondi A., Lo Coco F., Grignani F., Pelicci P. G. Acute promyelocyte leukemia; From genetics to treatment. Blood 1994; 83: 10–25
   PubMed Web of Science ®Google Scholar
• Richman C. M., Rowley J. D. Correlation of in vitro culture pattern and Q-banded karyotype in acute nonlymphocytic leukemia. Am. J. Hematol. 1983; 14: 37–47
   PubMed Web of Science ®Google Scholar
• Gustavsson A., Mitelman F., Olofsson T., Olsson I. The relationship between growth in agar, karyotype and prognosis in acute leukaemia. Scand. J. Haematol. 1984; 32: 351–363
   PubMedGoogle Scholar